Source: BIOSPACE

Masters Pharmaceuticals: <b>Masters Speciality Pharma</b> Signs Exclusivity Agreement With Speciality European Pharma For The Exclusive Distribution Of Mitocin®/Mitem® 20mg (mitomycin)

UK Masters Speciality Pharma is pleased to announce a partnership agreement with Speciality European Pharma (SEP) for the exclusive distribution of Mitocin/Mitem (mitomycin) to the Caribbean, Egypt, Kuwait, Iran, Saudi Arabia, UAE, Kenya, Seychelles, Uganda, Zimbabwe, Chile, Denmark, Greece, Ireland, Norway and Sweden.Masters has 30 years experience in the ethical and compliant supply...

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
25-100
Zulf Masters's photo - Founder & CEO of Masters Speciality Pharma

Founder & CEO

Zulf Masters

CEO Approval Rating

90/100